He Jie Tang in the treatment of chronic hepatitis B patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

331

HTML

2359

Tables (1-4)

172

Sum=2862

Nov 14, 2005 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Nov 14, 2005; 11(42): 6638-6643
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6638

Table 2 T lymphocyte subsets before and after the treatment (mean±SD)

Pre-T: before treatment; Post-T: after treatment;

^bP<0.01 vs group III ;

^aP＜0.05 vs before treatment in the same group.

Citation: Chen ZX, Zhang SJ, Lao SX, Hu HT, Zhang CY, Guan SH, Gu YL. He Jie Tang in the treatment of chronic hepatitis B patients. World J Gastroenterol 2005; 11(42): 6638-6643
URL: https://www.wjgnet.com/1007-9327/full/v11/i42/6638.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i42.6638